PaySign Inc (NAS:PAYS)

Q2 2025 Paysign Inc Earnings Call Transcript

Aug 5, 2025 / 09:00 PM GMT

Release Date Price: $7.12 (-0.56%)

Transcript 10-Q8-K

Key Points

Positve

PaySign Inc (PAYS) reported record revenue of $19.1 million for Q2 2025, marking a 33% increase compared to the same quarter last year.
The company's gross margins improved significantly, rising by 870 basis points to 61.6%.
The patient affordability business saw a remarkable revenue growth of 190% year over year, reaching $7.75 million.
PaySign Inc (PAYS) launched 7 new programs in Q2, with a total of 21 programs in the first half of the year, surpassing last year's pace.
The company plans to open a new state-of-the-art patient services contact center to increase support capacity fourfold, enhancing service levels for pharmaceutical companies and patients.

Negative

Revenue from the plasma compensation business declined by 4.7% year over year, although it increased sequentially by 14.2%.
The company faced one-time expenses of approximately $300,000 related to the onboarding of 123 transitioning plasma centers.
A plasma customer plans to close 22 underperforming donation centers, which could impact donor retention.
The plasma business continues to face headwinds due to an oversupply of source plasma and increased collection efficiencies.
Gross dollars loaded to cards decreased by 3.7%, and the total number of loads decreased by 4.6%, indicating challenges in the plasma segment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PAYS.OQ - Paysign Inc
Q2 2025 Paysign Inc Earnings Call
Aug 05, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the pay signing 2nd quarter 2025 earnings conference call. After the speaker's remarks, there'll be a question and answer session. You may be placed into question queue by pressing 1 on your telephone keypad. As a reminder, this conference call is being recorded.

The comments on today's call regarding Payside's financial results will be on a GAAP basis unless otherwise noted.

PaySign's earnings release was disseminated to the SEC earlier today and can be found on the investor relations section of our website PaySign.com, which includes reconciliations of non-gap measures to GAAP reported amounts. Additionally,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.